Max Robotics — Global Service Robot Directory + US Certification

About

Manabu Takai is a Japanese urologic surgeon and researcher whose work centers on advancing surgical treatments for prostate and bladder cancers, with a particular focus on robot-assisted techniques. His major contributions lie in evaluating and refining robot-assisted radical prostatectomy (RARP) for high-risk and metastatic prostate cancer, demonstrating that cytoreductive RARP can improve oncological outcomes in patients with metastatic disease. He has also developed and validated standardized training systems for RARP and robot-assisted radical cystectomy, notably the “Trisection Method,” which helps train novice surgeons while maintaining patient safety at low-volume institutions. His research extends to partial nephrectomy and renal function recovery, as well as rare urologic tumors, including a solitary fibrous tumor of the prostate. With several papers accumulating 6–10 citations each, his work on biochemical recurrence after chemohormonal therapy followed by RARP and on neoadjuvant LHRH antagonist therapy for high-risk prostate cancer has informed clinical decision-making. Takai’s dedication to surgical education and outcome optimization makes him a valuable contributor to the field of minimally invasive urologic oncology.